Walleye Trading LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 200 filers reported holding EDITAS MEDICINE INC in Q1 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2023$152,132
-84.5%
18,485
-86.4%
0.00%
-100.0%
Q1 2023$983,289
-74.0%
135,626
-68.2%
0.00%
-81.8%
Q4 2022$3,781,973
-31.4%
426,378
-5.4%
0.01%
-35.3%
Q3 2022$5,517,000
+18.5%
450,700
+14.5%
0.02%
+13.3%
Q2 2022$4,657,000
-48.5%
393,600
-17.3%
0.02%
-48.3%
Q1 2022$9,048,000
+162.0%
475,700
+265.8%
0.03%
+163.6%
Q4 2021$3,453,000
+42.7%
130,027
+120.8%
0.01%
+37.5%
Q3 2021$2,420,000
+0.8%
58,900
+39.0%
0.01%
-20.0%
Q2 2021$2,400,000
+179.7%
42,372
+107.4%
0.01%
+150.0%
Q1 2021$858,000
+18.7%
20,426
+98.1%
0.00%
+33.3%
Q4 2020$723,000
+113.9%
10,310
-14.4%
0.00%
+200.0%
Q3 2020$338,000
-18.2%
12,041
-13.7%
0.00%
-50.0%
Q2 2020$413,000
-11.4%
13,959
-40.6%
0.00%
-33.3%
Q1 2020$466,000
-38.7%
23,488
-8.5%
0.00%
-40.0%
Q4 2019$760,000
+36.4%
25,671
+4.9%
0.01%
+25.0%
Q3 2019$557,000
-37.1%
24,480
-31.6%
0.00%
-50.0%
Q2 2019$885,000
+147.9%
35,796
+145.2%
0.01%
+300.0%
Q1 2019$357,000
-89.1%
14,600
-89.9%
0.00%
-91.7%
Q4 2018$3,278,000
+115.1%
144,074
+200.7%
0.02%
+166.7%
Q3 2018$1,524,000
-28.6%
47,907
-19.6%
0.01%
-18.2%
Q2 2018$2,134,000
-34.9%
59,566
-39.8%
0.01%
-38.9%
Q1 2018$3,279,00098,9250.02%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2018
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders